Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lena M. Bolten"'
Autor:
Richard Lester, Jay JH Park, Lena M. Bolten, Allison Enjetti, James C. Johnston, Kevin Schwartzman, Binyam Tilahun, Arne von Delft
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 16, Iss , Pp - (2019)
To attain the Global End Tuberculosis (TB) goals, the treatment of persons with TB requires advancements in coordinated approaches that are low-cost and highly accessible. Treating TB successfully requires prolonged medication regimens with good adhe
Externí odkaz:
https://doaj.org/article/2843d12976fa48f2af3aea07f68b88a5
Autor:
Kate Gibson, Lauren Chong, Tim Jacobs, Patrick Farber, Antonios Samiotakis, Harveer Dhupar, Allison Goodman, Cindy-Lee Crichlow, Melissa Cid, Ping Xiang, Ahn Lee, Irene Yu, Gabrielle Conaghan, Nathalie Blamey, Vivian Li, Valentine de Puyraimond, Patrick Rowe, Stephanie K Masterman, Raffi Tonikian, Bryan C Barnhart, Juntao (Matt) Mai, Philippe Pouliot, Kate Caldwell, Lauren Clifford, Janice Reimer, Karine Herve, John Marwick, Lena M Bolten, Tova Pinsky, Gesa Volkers, Girija Bodhankar, Caitlyn De Jong, Sophie Cullen, Stefan Hannie, Rhys Chappell, Emma Lathouwers, Kirstin Brown, Mark Fogg, Aaron Yamniuk
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d71de961c12640bd9fb3d2088e75ea52
Autor:
Juntao (Matt) Mai, Kate Caldwell, Lindsay DeVorkin, Grace P. Leung, Karine Herve, Yuri Hwang, Cristina Faralla, Wei Wei, Emma Lathouwers, Valentine de Puyraimond, Lauren Clifford, Rhys S. Chappell, Stefan Hannie, Katherine J. Lam, Harveer Dhupar, Tran N. Tran, Melissa Cid, Lena M. Bolten, Tova Pinsky, Ping Xiang, Courteney Lai, Ahn Lee, Vivian Z. Li, Patrick Chan, Jasmine Chin, Steve Booth, Amy C. Lee, Stephanie Masterman, Sherie Duncan, Aaron Yamniuk, Kush Dalal, Tim M. Jacobs, Raffi Tonikian, Bryan C. Barnhart
Publikováno v:
Cancer Research. 83:1886-1886
In this study, we describe the characterization and validation of a diverse panel of fully human CD3-binding antibodies, including hundreds of human and cyno cross-reactive binders. We used two proof-of-concept TCE targets to demonstrate that this pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47061b8b3f04aed268ae085c8e24ab8e
https://doi.org/10.1158/1538-7445.am2023-1886
https://doi.org/10.1158/1538-7445.am2023-1886
Autor:
Lindsay DeVorkin, Tim M. Jacobs, Raffi Tonikian, Karine Hervé, Kate Caldwell, Yuri Hwang, Cristina Faralla, Wei Wei, Katherine J. Lam, Harveer Dhupar, Tran NT Tran, Melissa Cid, Lena M. Bolten, Tova Pinsky, Kush Dalal, Kevin A. Heyries, Bryan C. Barnhart
Publikováno v:
Cancer Research. 82:312-312
Bispecific antibodies that redirect cancer-killing T cells towards tumors are promising next-generation cancer therapies. While there are hundreds of T cell engagers (TCEs) in development, there is only one approved and marketed CD3-binding TCE. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::defd9b99e04a1dd1f9d39925803901db
https://doi.org/10.1158/1538-7445.am2022-312
https://doi.org/10.1158/1538-7445.am2022-312
Autor:
Binyam Tilahun, Kevin Schwartzman, Arne von Delft, Richard T. Lester, Lena M. Bolten, Jay Jh Park, James C. Johnston, Allison Enjetti
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 16, Iss, Pp-(2019)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
To attain the Global End Tuberculosis (TB) goals, the treatment of persons with TB requires advancements in coordinated approaches that are low-cost and highly accessible. Treating TB successfully requires prolonged medication regimens with good adhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc0dcbad14ba2215c50e66283006a2c
http://www.sciencedirect.com/science/article/pii/S240557941830041X
http://www.sciencedirect.com/science/article/pii/S240557941830041X